| Breakdown | TTM | Jun 2025 | Jun 2024 | Sep 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.74M | 15.81M | 26.00M | 36.44M | 23.07M | 24.10M |
| Gross Profit | 19.80M | 10.87M | 12.82M | 21.02M | 14.87M | 11.90M |
| EBITDA | 50.44M | -12.12M | -9.72M | -5.05M | -3.76M | 2.46M |
| Net Income | -122.93M | -13.68M | -23.66M | -16.93M | -2.10M | 2.98M |
Balance Sheet | ||||||
| Total Assets | 271.14M | 123.81M | 23.51M | 63.80M | 48.49M | 27.25M |
| Cash, Cash Equivalents and Short-Term Investments | 1.62M | 2.98M | 661.41K | 4.49M | 7.15M | 14.53M |
| Total Debt | 212.46M | 27.78M | 13.45M | 26.34M | 15.45M | 864.06K |
| Total Liabilities | 222.43M | 33.71M | 17.00M | 35.96M | 19.70M | 6.04M |
| Stockholders Equity | 48.72M | 90.10M | 6.52M | 28.34M | 28.73M | 21.22M |
Cash Flow | ||||||
| Free Cash Flow | -17.75M | -8.81M | -1.03M | -734.89K | -5.63M | 1.52M |
| Operating Cash Flow | -17.53M | -8.42M | -101.38K | 202.68K | 521.87K | 2.94M |
| Investing Cash Flow | -141.96M | -99.29M | -3.38M | -2.57M | -11.61M | -1.28M |
| Financing Cash Flow | 160.70M | 110.03M | -353.79K | -285.33K | 3.70M | 11.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
50 Neutral | $64.62M | -7.17 | ― | ― | 105.31% | 95.66% | |
50 Neutral | $61.52M | -1.40 | -102.66% | ― | -37.41% | 60.58% | |
49 Neutral | $269.00M | 18.96 | 2.39% | ― | -23.61% | ― | |
47 Neutral | $140.50M | 1.12 | ― | ― | -10.90% | ― | |
46 Neutral | $89.11M | -0.25 | -51.54% | ― | -16.83% | -485.31% | |
42 Neutral | $54.44M | -0.15 | -468.50% | ― | ― | ― |
On January 30, 2026, Upexi, Inc. entered into a Common Stock Sales Agreement with A.G.P./Alliance Global Partners to allow the company to sell shares of its common stock from time to time in an at-the-market offering under its effective shelf registration statement. On February 4, 2026, Upexi filed a related prospectus supplement with the U.S. Securities and Exchange Commission, setting up a structure under which the sales agent will sell shares on Nasdaq or other permitted markets or in privately negotiated transactions, for a 3.0% commission on gross proceeds, providing Upexi with a flexible mechanism to raise equity capital as needed.
The most recent analyst rating on (UPXI) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Upexi stock, see the UPXI Stock Forecast page.